Effectiveness of Statins on Lipid Goal Attainment and Lipid Parameters in Percutaneous Coronary Intervention Patients
Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 25 May 2016
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Cardiovascular disorders; Hypercholesterolaemia
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 10 May 2016 Status changed from completed to withdrawn prior to enrolment.
- 08 Oct 2015 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 30 Sep 2015 New trial record